BioCatch
BioCatch is a Fraud Prevention & Risk Signals company founded in 2011 and based in Tel Aviv, Israel. It is valued at $1.3B.
BioCatch was founded in 2011 in Tel Aviv by Avi Turgeman, Benny Rosenbaum and Uri Rivner. Its BioCatch Connect platform collects more than 3,000 anonymized data points per session, including keystroke, mouse and touch behavior and AI-agent usage, and scores them to flag account-opening fraud, account takeover, social-engineering scams and mule accounts. It sells the platform to banks and other financial institutions. BioCatch passed $100 million in annual recurring revenue in 2023 and reached EBITDA profitability, according to Permira, whose funds bought a majority stake in May 2024 at a $1.3 billion enterprise value, mainly from Bain Capital Tech Opportunities and Maverick Ventures. On August 3, 2026, Visa agreed to acquire BioCatch for $2.4 billion in cash from Permira-advised funds and other shareholders. The deal is pending regulatory approvals and is expected to close by the end of Visa's fiscal second quarter of 2027; until then BioCatch remains an independent company led by CEO Gadi Mazor.
BioCatch gives banks a fraud signal that document and selfie checks do not capture: how a session behaves once a customer is logged in. Its models cover 1.8 billion devices and 760 million users across more than 350 banking clients in 21 countries, and analyze 19 billion user sessions a month. Visa's pending $2.4 billion purchase, announced August 3, 2026, would place that behavioral intelligence inside Visa's payments network.
At a glance
Total raised
Undisclosed
Headcount
—
Headquarters
Tel Aviv
IsraelFounded
2011
Status
Private
Latest valuation
Where BioCatch ranks
Top 25 Digital Identity companies →Funding history
Total raised
—
Rounds tracked
1
Latest stage
Private Equity
Latest valuation
$1.3B
| Date | Stage | Amount | Valuation | Lead investors |
|---|---|---|---|---|
| May 2, 2024 | Private Equity | — | $1.3B | Permira |